Rheumatology Advance Access originally published online on July 24, 2007
Rheumatology 2007 46(9):1510; doi:10.1093/rheumatology/kem111
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Re: Pulmonary arterial hypertension in connective tissue diseases
Department of Rheumatology, 1Department of Cardiology and 2Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B 9000 Gent, Belgium
Correspondence to: V. Smith MD, Department of Rheumatology, Ghent University Hospital, De Pintelaan 185, B 9000 Gent, Belgium. E-mail: vanessa.smith@ugent.be
| The first 10% of the full text of this article appears below. |
SIR, In their review of pulmonary arterial hypertension in connective tissue diseases, Kahler and Colleselli [1] discuss the epidemiology, pathophysiology, diagnostic tools and treatment options of this disease. However, in